about
Osteosarcoma: Cells-of-Origin, Cancer Stem Cells, and Targeted TherapiesNew small molecules targeting apoptosis and cell viability in osteosarcomaParis polyphylla Suppresses Proliferation and Vasculogenic Mimicry of Human Osteosarcoma Cells and Inhibits Tumor Growth In Vivo.Docetaxel, bevacizumab, and gemcitabine for very high risk sarcomas in adolescents and young adults: A single-center experience.Inhibition of KLF4 by Statins Reverses Adriamycin-Induced Metastasis and Cancer Stemness in Osteosarcoma CellsCD8(+)/FOXP3(+)-ratio in osteosarcoma microenvironment separates survivors from non-survivors: a multicenter validated retrospective study.Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.B7-H4 expression is associated with tumor progression and prognosis in patients with osteosarcoma.The Protein Tyrosine Phosphatase Rptpζ Suppresses Osteosarcoma Development in Trp53-Heterozygous Mice.Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells.Hypoxia-activated pro-drug TH-302 exhibits potent tumor suppressive activity and cooperates with chemotherapy against osteosarcoma.RETRACTED: Up-regulation of miR-130b expression level and down-regulation of miR-218 serve as potential biomarker in the early detection of human osteosarcomaResveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cellsThe miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene.Molecular profiling of childhood cancer: Biomarkers and novel therapiesLung cells support osteosarcoma cell migration and survival.MiR-193a-3p and miR-193a-5p suppress the metastasis of human osteosarcoma cells by down-regulating Rab27B and SRR, respectively.L-MTP-PE and zoledronic acid combination in osteosarcoma: preclinical evidence of positive therapeutic combination for clinical transfer.RANK and RANK ligand expression in primary human osteosarcoma.Icariside II, a natural mTOR inhibitor, disrupts aberrant energy homeostasis via suppressing mTORC1-4E-BP1 axis in sarcoma cellsMiR-34a-5p promotes the multi-drug resistance of osteosarcoma by targeting the CD117 gene.Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational controlThe iron chelator Dp44mT suppresses osteosarcoma's proliferation, invasion and migration: in vitro and in vivoNatural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy.Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene.Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-cateninIdentification of critical genes and gene interaction networks that mediate osteosarcoma metastasis to the lungs.Advances in emerging drugs for osteosarcoma.Withaferin-A Induces Apoptosis in Osteosarcoma U2OS Cell Line via Generation of ROS and Disruption of Mitochondrial Membrane Potential.Programmed cell death 1 correlates with the occurrence and development of MG63 osteosarcoma.Foscan and foslip based photodynamic therapy in osteosarcoma in vitro and in intratibial mouse models.Protein phosphatase 2A Cα regulates proliferation, migration, and metastasis of osteosarcoma cells.MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.5,7-Dihydroxy-4'-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells.Nucleotidyl transferase TUT1 inhibits lipogenesis in osteosarcoma cells through regulation of microRNA-24 and microRNA-29a.Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma.Activation Status of Receptor Tyrosine Kinases as an Early Predictive Marker of Response to Chemotherapy in Osteosarcoma.Anticancer efficacy of the hypoxia-activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma.miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
P2860
Q26745742-E619E9C0-1EC9-4CEC-8753-3691562E4873Q28547760-FEC5CB73-0982-4A55-8E97-9DEE6541FB0BQ32178720-30E33236-D2B7-42F2-9934-BB21C52449A8Q33439510-1B25CECB-9AB3-4997-812B-B57A70ABBE48Q33795254-DFF2D0D3-E7A8-4F9C-93C6-A9CD64AF1D3BQ35506606-7C4B033A-CAE0-43CB-8C7B-A77D41531688Q35511058-ED3B5482-D0EB-44ED-9835-E58A9A4C13EEQ35543730-130DA384-BB55-4E28-90AC-13E8826F67D2Q35770577-C632F760-2DC8-41FD-B961-3370D730E179Q35904214-32AABB24-1F46-465D-BCE3-D2507FFA082CQ36072569-E9635678-1E10-4216-8FB3-9E62EAA62037Q36131618-4183ECE2-8527-4701-BA35-3541DB66B913Q36224993-77866E5C-1877-4055-924C-2194C786F9F9Q36245752-F49E1A7C-DCAD-4731-8BA4-0614B20FD754Q36250783-E6A5272B-1523-4D64-81E7-DF556880C7DDQ36260257-AF3B14F7-CCA2-4BA4-B2B9-DAEB910C5E18Q36706415-FC09D42E-A61A-47F7-B0AC-30E86BC37FA0Q36853886-F1440C0D-FA09-4370-98EC-CD7F969F7730Q37179783-6DC7BCD0-C07A-46FA-8591-A28BC148F7E3Q37317409-10BFBA9E-4C59-45BE-88E9-267155C24628Q37317570-3981A778-33DA-41E6-92A6-B4855EF19C8AQ37435041-95A64EE4-6511-4D83-A743-58D3D4183D9EQ37553760-615C4757-2BD4-4DEF-BCB0-B11CA0EBD3C1Q37569758-5FE672E2-8C5B-48E4-9605-A879CE8E5D43Q37575208-7F5E444B-4B92-4EC5-90B8-207ABF0B5891Q37692351-355D00C2-2E64-41F4-B560-EE153F807698Q37718335-B3E4629B-5745-4F72-9B88-084B7F087732Q38453976-07404872-852A-4C4F-82AF-5F706742EDC1Q38506118-0F9D094B-872E-4F0B-8F7A-E8F13A20DE7FQ38694216-59F6882F-2E95-4785-819B-820909CD7F67Q38720431-218BA347-6105-40D8-92CB-D876DC73154EQ38726635-19F5FA2F-0AE8-4CB8-86AA-19B6F5451714Q38746890-5C65B897-2BD4-4AA2-A758-28748C613645Q38889691-F6D4D36D-5F28-46E7-9C93-28A89EDF8959Q38943380-698CC1F0-5B86-4A9F-8EFB-0F7BEE7E2DD3Q38964274-9183FC49-7E06-4069-87A5-6A5546AEFCB7Q39464836-B293A07C-8995-4393-B55D-22DFF75118C8Q41624093-EE1E1187-057E-46F3-992A-F466856427B3Q41712371-D063A18C-6AA1-42B6-B230-3461D4C45D1BQ41721537-9E477F93-3070-4ED7-8A14-A17D9A88EFA6
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Recent advances in osteosarcoma.
@en
type
label
Recent advances in osteosarcoma.
@en
prefLabel
Recent advances in osteosarcoma.
@en
P1476
Recent advances in osteosarcoma.
@en
P2093
Bruno Fuchs
Sander M Botter
P356
10.1016/J.COPH.2014.02.002
P50
P577
2014-03-13T00:00:00Z